Report Description

Whole Genome Sequencing Market is expected to grow with an impressive CAGR in the forecast period, 2024-2028. Whole Genome Sequencing Market (WGS) is a widely used application included in genome, microbial resequencing, and genome sequencing. It is expected to increase significantly with the growing research in genomics. Additionally, a rise in the usage of this technology against COVID-19 in sequencing the data of the COVID-19 virus is expected to drive the market growth.

Whole Genome Sequencing Market (WGS) technology can deliver quick results and high-quality data. It can be used to locate, monitor, and address disease outbreaks in a region. WGS is shown to be most useful in research and rarely in therapeutic treatments.

The mapping of novel organisms' genomes, the completion of the genomes of already-known organisms, or the comparison of genomes from other samples all benefiting from microbial whole-genome sequencing. To create reliable reference genomes, microbial identification, and other comparative genomic investigations, it is required to sequence the full bacterial, viral, and other microbial genomes.

Growing Technological Advancement

Increasing technological advancement in NGS instruments and update in technology utilized in Sequencing techniques is adding to further drive the sequencing market growth in the forecast period. Moreover, with its multiplexing feature, next-generation sequencing (NGS) enables microbiology researchers to sequence hundreds of organisms, unlike capillary sequencing or PCR-based methods. NGS-based microbial genome sequencing is time efficient and streamlines the workflow and does not rely on time-consuming cloning stages like older techniques. Additionally, low-frequency variations and genomic rearrangements that might be overlooked are too expensive to find using current techniques can be found using NGS (Next Generation Sequencing). Also, population-level WES (whole exome sequencing) data generation has increased in today’s time. The whole exome sequencing (WES) is a successful application in the field of sequencing and is proved by the discovery of the genes for the conditions such as Mendelian phenotypes, Miller’s disease and other diseases. Whole exome sequencing is more useful than whole genome sequencing since the majority of known disease-causing mutations take place in exons and is in high demand in the market and thus anticipate to propel the market growth in the future.


Download Free Sample Report
Growing Demand in Disease Diagnosis

Whole genome sequencing has an increased demand in clinical applications regarding the disease diagnosis and has significant importance in identification of mutation in a genome segment for isolating a variant or mutation in a gene. Moreover, techniques such as Microbial whole-genome resequencing involves the sequencing of the entire genome of a bacteria, virus, or other microbe, and comparing the sequence to that of a known reference and thus is helpful in disease diagnosis. This microbial genome sequencing is thus an important tool to microbial identification. Additionally, whole genome sequencing technique is used for identifying the order of bases in the organism and is thus utilized to produce a precise DNA fingerprint and thus can aid in linking the cases allowing the eruption or defect to be detected quickly and thus, is significant in infectious disease diagnosis to bolster the market growth in the forecast period.

Increased Application in Genome Mapping

The rising demand for genome mapping in government projects for the rising research and development related to disease diagnosis and research for improved treatment in cancer, mutated disorders, and other diseases, etc. Furthermore, governments of distinct countries and regions are sequencing millions of genomes to progress research and discover better ways to identify and cure cancer, uncommon disorders, and other ailments. For instance, the European government is undertaking efforts to improve the region’s large-scale genomic data with projects such as  the France’s French Plan for Genomic Medicine 2025 and similarly, the United Kingdom’s 100,000 Genomes Project. These initiatives have resulted in the growth of NGS Next-generation sequencing (NGS) informatics services in the region. For instance, in November 2022, using Nanopore Genome Sequencing, AI, and Cloud Computing, the scientists at the Stanford Medicine University sequenced a patient's whole genome in under five hours.

Recent Development

  • In November 2021, Illumina and Genetic Alliance announced a USD 120 million global initiative—iHope Genetic Health program. This initiative aims to offer Whole Genome Sequencing (WGS) access to various patients impacted by genetic disorders globally.
  • Also, In 2020, a leading company QIAGEN acquired the NeuMoDx Molecular and secured its position in  the market in automated molecular testing. The company now includes medium- and high-throughput NeuMoDx automation solutions based on PCR testing technology, as a new component of its updated product portfolio.

Market Segmentation

The whole Genome Sequencing Market is segmented based on the sequencing type, product type, application, end user, and region. Based on sequencing type, the market is segmented into large whole-genome sequencing and small genome sequencing. Based on product type, the market is segmented into instrument, kits, and service. Based on application, the market is segmented into diagnostics, drug discovery and development, personalized medicine, and others. Based on end user, the market is further fragmented into hospitals and clinics, pharmaceutical, and biotechnology companies, and others. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

GE Healthcare, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Agilent Technologies, 10 x Genomics, BGI, Oxford Nanopore, Nebula Genomics, Veritas Genetics, etc.., are some of the major players operating in the global Whole Genome Sequencing Market.

Attribute

Details

Base Year

2022

Historical Years

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Sequencing Type

Product Type

Application

End user

Regional Scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa; Kuwait

Key Companies Profiled

GE Healthcare, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Agilent Technologies, 10 x Genomics, BGI, Oxford Nanopore, Nebula Genomics, Veritas Genetics.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Whole Genome Sequencing Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Whole Genome Sequencing Market, By Sequencing Type:
    • Large Whole-Genome Sequencing
    • Small Genome Sequencing
  • Whole Genome Sequencing Market, By Product Type:
    • Instrument
    • Kits
    • Service
  • Whole Genome Sequencing Market, By Application:
    • Diagnostics
    • Drug Discovery and Development
    • Personalized Medicine
    • Others
  • Whole Genome Sequencing Market, By End User:
    • Hospitals and Clinics
    • Pharmaceutical and Biotechnology Companies
    •  Others
  • Whole Genome Sequencing Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Whole Genome Sequencing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Whole Genome Sequencing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered.

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Whole Genome Sequencing Market Outlook.

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Sequencing Type (Large Whole-Genome Sequencing and Small Genome Sequencing)

5.2.2.    By Product Type (Instrument, Kits, and Service)

5.2.3.    By Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others)

5.2.4.    By End User (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others)

5.2.5.    By Company (2022)

5.2.6.    By Region

5.3.  Product Market Map

6.    Asia-Pacific Whole Genome Sequencing Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    Sequencing Type

6.2.2.    Product Type

6.2.3.    Application

6.2.4.    End User

6.2.5.    By Country

6.3.  Asia-Pacific: Country Analysis

6.3.1.    China Whole Genome Sequencing Market Outlook.

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           Sequencing Type

6.3.1.2.2.           Product Type

6.3.1.2.3.           Application

6.3.1.2.4.           End User

6.3.2.    India Whole Genome Sequencing Market Outlook.

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           Sequencing Type

6.3.2.2.2.           Product Type

6.3.2.2.3.           Application

6.3.2.2.4.           End User  

6.3.3.    South Korea Whole Genome Sequencing Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           Sequencing Type

6.3.3.2.2.           Product Type

6.3.3.2.3.           Application

6.3.3.2.4.           End User

6.3.4.    Japan Whole Genome Sequencing Market Outlook

6.3.4.1.        Market Size & Forecast

6.3.4.1.1.           By Value

6.3.4.2.        Market Share & Forecast

6.3.4.2.1.           Sequencing Type

6.3.4.2.2.           Product Type

6.3.4.2.3.           Application

6.3.4.2.4.           End User

6.3.5.    Australia Whole Genome Sequencing Market Outlook

6.3.5.1.        Market Size & Forecast

6.3.5.1.1.           By Value

6.3.5.2.        Market Share & Forecast

6.3.5.2.1.           Sequencing Type

6.3.5.2.2.           Product Type

6.3.5.2.3.           Application

6.3.5.2.4.           End User

7.    Europe Whole Genome Sequencing Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    Sequencing Type

7.2.2.    Product Type

7.2.3.    Application

7.2.4.    End User

7.2.5.    By Country

7.3.  Europe: Country Analysis

7.3.1.    France Whole Genome Sequencing Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           Sequencing Type

7.3.1.2.2.           Product Type

7.3.1.2.3.           Application

7.3.1.2.4.           End User

7.3.2.    Germany Whole Genome Sequencing Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           Sequencing Type

7.3.2.2.2.           Product Type

7.3.2.2.3.           Application

7.3.2.2.4.           End User

7.3.3.    United Kingdom Whole Genome Sequencing Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           Sequencing Type

7.3.3.2.2.           Product Type

7.3.3.2.3.           Application

7.3.3.2.4.           End User

7.3.4.    Italy Whole Genome Sequencing Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           Sequencing Type

7.3.4.2.2.           Product Type

7.3.4.2.3.           Application

7.3.4.2.4.           End User

7.3.5.    Spain Whole Genome Sequencing Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           Sequencing Type

7.3.5.2.2.           Product Type

7.3.5.2.3.           Application

7.3.5.2.4.           End User

7.3.6.    North America Humic-based bio stimulants Market Outlook.

7.4.  Market Size & Forecast       

7.4.1.    By Value

7.5.  Market Share & Forecast

7.5.1.    Sequencing Type

7.5.2.    Product Type

7.5.3.    Application

7.5.4.    End User

7.5.5.    By Country

7.6.  North America: Country Analysis

7.6.1.    United States Whole Genome Sequencing Market Outlook

7.6.1.1.        Market Size & Forecast

7.6.1.1.1.           By Value

7.6.1.2.        Market Share & Forecast

7.6.1.2.1.           Sequencing Type

7.6.1.2.2.           Product Type

7.6.1.2.3.           Application

7.6.1.2.4.           End User

7.6.2.    Mexico Whole Genome Sequencing Market Outlook

7.6.2.1.        Market Size & Forecast

7.6.2.1.1.           By Value

7.6.2.2.        Market Share & Forecast

7.6.2.2.1.           Sequencing Type

7.6.2.2.2.           Product Type

7.6.2.2.3.           Application

7.6.2.2.4.           End User

7.6.3.    Canada Whole Genome Sequencing Market Outlook

7.6.3.1.        Market Size & Forecast

7.6.3.1.1.           By Value

7.6.3.2.        Market Share & Forecast

7.6.3.2.1.           Sequencing Type

7.6.3.2.2.           Product Type

7.6.3.2.3.           Application

7.6.3.2.4.           End User

8.    South America Whole Genome Sequencing Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    Sequencing Type

8.2.2.    Product Type

8.2.3.    Application

8.2.4.    End User

8.2.5.    By Country

8.3.  South America: Country Analysis

8.3.1.    Brazil Whole Genome Sequencing Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           Sequencing Type

8.3.1.2.2.           Product Type

8.3.1.2.3.           Application

8.3.1.2.4.           End User

8.3.2.    Argentina Whole Genome Sequencing Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           Sequencing Type

8.3.2.2.2.           Product Type

8.3.2.2.3.           Application

8.3.2.2.4.           End User

8.3.3.    Colombia Whole Genome Sequencing Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           Sequencing Type

8.3.3.2.2.           Product Type

8.3.3.2.3.           Application

8.3.3.2.4.           End User

9.    Middle East and Africa Whole Genome Sequencing Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    Sequencing Type

9.2.2.    Product Type

9.2.3.    Application

9.2.4.    End User

9.2.5.    By Country

9.3.  MEA: Country Analysis

9.3.1.    South Africa Whole Genome Sequencing Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           Sequencing Type

9.3.1.2.2.           Product Type

9.3.1.2.3.           Application

9.3.1.2.4.           End User

9.3.2.    Saudi Arabia Whole Genome Sequencing Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           Sequencing Type

9.3.2.2.2.           Product Type

9.3.2.2.3.           Application

9.3.2.2.4.           End User

9.3.3.    UAE Whole Genome Sequencing Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           Sequencing Type

9.3.3.2.2.           Product Type

9.3.3.2.3.           Application

9.3.3.2.4.           End User

9.3.4.    Kuwait Whole Genome Sequencing Market Outlook

9.3.4.1.        Market Size & Forecast

9.3.4.1.1.           By Value

9.3.4.2.        Market Share & Forecast

9.3.4.2.1.           Sequencing Type

9.3.4.2.2.           Product Type

9.3.4.2.3.           Application

9.3.4.2.4.           End User

10. Market Dynamics

10.1.             Drivers

10.2.             Challenges

11. Market Trends & Developments

11.1.             Recent Developments

11.2.             Mergers & Acquisitions

11.3.             Product Developments

12. Competitive Landscape

12.1.             Business Overview

12.2.             Company Snapshot

12.3.             Products & Services

12.4.             Financials (In case of listed companies)

12.5.             Recent Developments

12.6.             SWOT Analysis

12.6.1.  GE Healthcare, Inc.

12.6.2.  Illumina, Inc.

12.6.3.   QIAGEN N.V.

12.6.4.  Thermo Fisher Scientific

12.6.5.  Agilent Technologies

12.6.6.  10 x Genomics

12.6.7.  BGI

12.6.8.  Oxford Nanopore

12.6.9.  Nebula Genomics

12.6.10.                Veritas Genetics.

13. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The rising demand for Whole Genome Sequencing Market in diagnosis of genetic diseases, mutations, microbial resequencing, and growing advancement in whole genome sequencing ,etc., are factors driving the growth of the Whole Genome Sequencing Market in the forecast years, 2024-2028.

down-arrow

GE Healthcare, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Agilent Technologies, 10 x Genomics, BGI, Oxford Nanopore, Nebula Genomics, Veritas Genetics etc. are some of the leading the Whole Genome Sequencing Market in the forecast period, 2024-2028.

down-arrow

North America is estimated to dominate the Whole Genome Sequencing Market on account of increased utilization of whole genome sequencing in research & development for the development for new and advanced molecular diagnostic tests alongwith a strong healthcare investment and infrastructure in the region.

down-arrow

The high cost and hectic and precise use of whole genome sequencing are some of the key factors hampering the growth of Whole Genome Sequencing Market in the forecast period.

profile

Sakshi Bajaal

Business Consultant
Press Release

Whole Genome Sequencing Market to be Dominated by the Diagnostics Segment by 2028

Apr, 2023

Rising number of genetic diseases and growing demand for genetic research is expected to drive the Global Whole Genome Sequencing Market in the forecast period, 2024-2028.